FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental pharmacology and surgery, and can be used to simulate critical skeletal muscle ischemia. Method for pharmacological correction of experimental critical skeletal muscle ischemia with a combination of simvastatin, udenafil and mononuclear fraction of autologous bone marrow involves experimental modeling of critical ischemia of shin muscles, where simvastatin is administered intragastrically in dose of 0.86 mg/kg, udenafil is administered intragastrically in dose of 0.86 mg/kg once a day daily for 7 days and a mononuclear fraction of autologous bone marrow is introduced once parenterally on 7th day after simulating critical ischemia 50 mcl into 4 points.
EFFECT: invention provides developing a method for pharmacological correction of critical shin muscles ischemia in experimental simvastatin animals.
1 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2735838C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND UDENAFIL | 2020 |
|
RU2727891C1 |
METHOD OF TREATING CHRONIC LIMB ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2556606C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH SIMVASTATIN | 2020 |
|
RU2726076C1 |
METHOD FOR SKELETAL MUSCLE EXPERIMENTAL ISCHEMIA PHARMACOLOGICAL CORRECTION USING SILDENAFIL AND PENTOXIFYLLINE IN COMBINED THERAPY | 2016 |
|
RU2618621C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH SILNEDAFIL INCLUDING IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2012 |
|
RU2497203C2 |
METHOD FOR SKELETAL MUSCLE EXPERIMENTAL ISCHEMIA PHARMACOLOGICAL CORRECTION USING VARDENAFIL AND PENTOXIFYLLINE IN COMBINED THERAPY | 2016 |
|
RU2618622C1 |
METHOD FOR SKELETAL MUSCLE EXPERIMENTAL ISCHEMIA PHARMACOLOGICAL CORRECTION USING TADALAFIL AND PENTOXIFYLLINE IN COMBINED THERAPY | 2016 |
|
RU2618620C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF SKELETAL MUSCLE WITH RESVERATROL | 2012 |
|
RU2518965C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH MINOXIDIL | 2012 |
|
RU2497200C1 |
Authors
Dates
2020-07-08—Published
2020-03-21—Filed